Isolation and characterization of β-transducin repeat-containing protein ligands screened using a high-throughput screening system
XINTONG LIU(RIKEN), Nobumoto Watanabe(RIKEN Advanced Science Institute)
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
January 1, 2023
Cited by 2
Related Papers
Deficiency in Chromosome Congression by the Inhibition of Plk1 Polo Box Domain-dependent Recognition
|Journal of Biological Chemistry|2008|110
Identification of a small‐molecule ligand of <i>β</i>‐arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells
|Cancer Medicine|2018|12
Identification of antimycin A as a c-Myc degradation accelerator via high-throughput screening
|Journal of Biological Chemistry|2023|7
Identification of microbial metabolites that accelerate the ubiquitin-dependent degradation of c-Myc
|Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics|2023|5